Cargando…
Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism
Uterine leiomyoma is the most common benign smooth muscle tumor of uterus in women of reproductive age, with a high lifetime incidence. Nowadays, the exploration on the pharmacotherapies, such as progesterone receptor antagonist (PRA) requires more attention. Hence, the current study aimed to examin...
Autores principales: | Zhang, Lindong, Feng, Quanling, Wang, Zhiting, Liu, Pingping, Cui, Shihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646233/ https://www.ncbi.nlm.nih.gov/pubmed/31262976 http://dx.doi.org/10.1042/BSR20190094 |
Ejemplares similares
-
Expression of Concern: Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism
Publicado: (2021) -
Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma
por: Tanioka, Saki, et al.
Publicado: (2022) -
Loss of the repressor REST affects progesterone receptor function and promotes uterine leiomyoma pathogenesis
por: Cloud, Ashley S., et al.
Publicado: (2022) -
Differential regulatory effect of progesterone on the proliferation and apoptosis of uterine leiomyoma tissue explants and primary leiomyoma cell cultures
por: Voronin, Dmitry, et al.
Publicado: (2021) -
A Role for Progesterone-Regulated sFRP4 Expression in Uterine Leiomyomas
por: Delaney, Meaghan A., et al.
Publicado: (2017)